Neoadjuvant Chemotherapy in Combination with Toripalimab trials for Breast cancer

All Neoadjuvant Chemotherapy in Combination with Toripalimab trials · All Breast cancer trials

Phase breakdown

Recruiting trials studying Neoadjuvant Chemotherapy in Combination with Toripalimab for Breast cancer

• Neoadjuvant Chemotherapy in Combination With Toripalimab for HR+/HER2- Breast Cancer (NEOTORCH-BREAST01)
  NCT06611813 · Phase: Phase 2 · Ages: 18 Years to 75 Years · Sex: Female · 11 locations
• Neoadjuvant Chemotherapy in Combination With Toripalimab for HR+/HER2- Breast Cancer : a Randomized, Open-label, Parallel-controlled, Multi-center Phase III Study (NEOTORCH-BREAST04)
  NCT06977893 · Phase: Phase 3 · Ages: 18 Years to 75 Years · Sex: Female · 13 locations
• Neoadjuvant Therapy Combined With Trastuzumab Rezetecan and Toripalimab for HR+/HER2-low Breast Cancer (NEOTORCH-BREAST 08)
  NCT07383818 · Phase: Phase 2 · Ages: 18 Years to 70 Years · Sex: Female · 5 locations

Common questions

How many trials study Neoadjuvant Chemotherapy in Combination with Toripalimab for Breast cancer?

3 recruiting trials.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.